Bellerophon Therapeutics, Inc.
BLPH
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | -5.14M | 2.82M | -5.02M | -5.07M |
| Total Depreciation and Amortization | 0.00 | 1.00K | 1.00K | 4.00K | 21.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -119.00K | 133.00K | 264.00K | 161.00K | 217.00K |
| Change in Net Operating Assets | -4.29M | 83.00K | 179.00K | 499.00K | -179.00K |
| Cash from Operations | -6.33M | -4.92M | 3.27M | -4.35M | -5.01M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 140.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 140.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 3.57M | 1.44M | -- | -- |
| Repurchase of Common Stock | 0.00 | -2.00K | -- | -40.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.55M | 3.55M | -- | -- |
| Cash from Financing | 0.00 | 26.00K | 4.98M | -40.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.19M | -4.90M | 8.25M | -4.39M | -5.01M |
